{"component": "clause", "props": {"groups": [{"samples": [{"hash": "hsETgh52B4k", "uri": "/contracts/hsETgh52B4k#development-milestone", "label": "License Agreement", "score": 26.8590006845, "published": true}, {"hash": "7DGrrYr1V5J", "uri": "/contracts/7DGrrYr1V5J#development-milestone", "label": "License Agreement", "score": 26.6125941136, "published": true}], "size": 6, "snippet": "The development milestone has been made in a way to ensure completion of the said Project within 3 (Three) years from the date of issue of Notice of Allotment (NoA).", "snippet_links": [{"key": "the-development", "type": "clause", "offset": [0, 15]}, {"key": "to-ensure", "type": "clause", "offset": [49, 58]}, {"key": "completion-of-the", "type": "clause", "offset": [59, 76]}, {"key": "said-project", "type": "definition", "offset": [77, 89]}, {"key": "notice-of", "type": "clause", "offset": [139, 148]}], "hash": "c64ae397be78713a569a6df6622f4c6d", "id": 1}, {"samples": [{"hash": "hN1KSLi8Ej5", "uri": "/contracts/hN1KSLi8Ej5#development-milestone", "label": "Collaboration, Development and License Agreement (TESARO, Inc.)", "score": 28.1594798084, "published": true}, {"hash": "adjrztWVjTY", "uri": "/contracts/adjrztWVjTY#development-milestone", "label": "Collaboration, Development and License Agreement (TESARO, Inc.)", "score": 27.841889117, "published": true}], "size": 4, "snippet": "ZAI shall pay to TESARO the following one-time milestone payments within [***] following the first achievement of the corresponding milestone events set forth below by ZAI, its Affiliates or sublicensees for any Licensed Compound or Licensed Product. For purposes of clarity, the milestone payment set forth below shall be payable only upon the first achievement of such milestone, and shall not be payable more than once, regardless of whether more than one Licensed Compound or Licensed Product achieves such milestone. [***] $[***] Notwithstanding the foregoing, if ZAI\u2019s Development activities cause TESARO to owe Merck a milestone payment under the \u201cDevelopment Milestone\u201d section of Section 7.02 of the Merck Agreement and TESARO has not received from ZAI a corresponding milestone payment under this Section 8.2(a), then ZAI shall pay to TESARO, in accordance with the terms of this Agreement the amount of the milestone payment owed by TESARO to Merck.", "snippet_links": [{"key": "pay-to", "type": "definition", "offset": [10, 16]}, {"key": "payments-within", "type": "clause", "offset": [57, 72]}, {"key": "following-the", "type": "definition", "offset": [79, 92]}, {"key": "milestone-events", "type": "definition", "offset": [132, 148]}, {"key": "by-zai", "type": "clause", "offset": [165, 171]}, {"key": "licensed-compound", "type": "definition", "offset": [212, 229]}, {"key": "licensed-product", "type": "clause", "offset": [233, 249]}, {"key": "for-purposes-of", "type": "clause", "offset": [251, 266]}, {"key": "notwithstanding-the-foregoing", "type": "clause", "offset": [535, 564]}, {"key": "development-activities", "type": "clause", "offset": [575, 597]}, {"key": "merck-agreement", "type": "definition", "offset": [709, 724]}, {"key": "in-accordance-with", "type": "definition", "offset": [853, 871]}, {"key": "terms-of-this-agreement", "type": "clause", "offset": [876, 899]}, {"key": "payment-owed", "type": "clause", "offset": [928, 940]}], "hash": "448a1f9bdde0cca88b1ab73dc72e7bd6", "id": 2}, {"samples": [{"hash": "11jeBN1j6fC", "uri": "/contracts/11jeBN1j6fC#development-milestone", "label": "Lease Agreement", "score": 25.1067761807, "published": true}], "size": 3, "snippet": "The development milestone has been made in a way to ensure completion of the said Project within 15 years of signing of Lease Cum Development Agreement.", "snippet_links": [{"key": "the-development", "type": "clause", "offset": [0, 15]}, {"key": "to-ensure", "type": "clause", "offset": [49, 58]}, {"key": "completion-of-the", "type": "clause", "offset": [59, 76]}, {"key": "said-project", "type": "definition", "offset": [77, 89]}, {"key": "signing-of-lease", "type": "clause", "offset": [109, 125]}, {"key": "development-agreement", "type": "clause", "offset": [130, 151]}], "hash": "8b6fc905b806397df8f3847daf60bd85", "id": 3}, {"samples": [{"hash": "CTFXz6Ytzc", "uri": "/contracts/CTFXz6Ytzc#development-milestone", "label": "License Agreement (Ovid Therapeutics Inc.)", "score": 27.3319644079, "published": true}, {"hash": "57FvqQtBO4O", "uri": "/contracts/57FvqQtBO4O#development-milestone", "label": "License Agreement (Ovid Therapeutics Inc.)", "score": 27.2142368241, "published": true}], "size": 2, "snippet": "Upon Successful Completion of the first Phase III Clinical Trial for Product (the \u201cDevelopment Milestone Event\u201d), Ovid shall pay to Lundbeck Ten Million Dollars (USD 10,000,000) (the \u201cDevelopment Milestone Amount\u201d).", "snippet_links": [{"key": "completion-of-the", "type": "clause", "offset": [16, 33]}, {"key": "phase-iii-clinical-trial", "type": "definition", "offset": [40, 64]}, {"key": "development-milestone-event", "type": "definition", "offset": [83, 110]}, {"key": "pay-to", "type": "definition", "offset": [125, 131]}, {"key": "milestone-amount", "type": "definition", "offset": [196, 212]}], "hash": "47b6a42d6c2ac16bf47c64b5f8b02869", "id": 4}, {"samples": [{"hash": "ep05kbNgvtr", "uri": "/contracts/ep05kbNgvtr#development-milestone", "label": "License Agreement (Zenas BioPharma, Inc.)", "score": 35.6392881588, "published": true}, {"hash": "jo9C3IooZx4", "uri": "/contracts/jo9C3IooZx4#development-milestone", "label": "License Agreement (Zenas BioPharma, Inc.)", "score": 35.0643394935, "published": true}], "size": 2, "snippet": "Initiation of first Clinical Study of the Licensed Asset or a Product in the Licensed Territory XENCOR may exercise its option in accordance with Section 9.2.1(a). [***] [***] [***] [***] [***] [***] [***] [***] [***] [***]\n(a) At XENCOR\u2019s option, to be elected by 30-days advance written notice to Licensee (the \u201cConsideration Election Notice\u201d), payment of either: [***].", "snippet_links": [{"key": "clinical-study", "type": "clause", "offset": [20, 34]}, {"key": "licensed-asset", "type": "definition", "offset": [42, 56]}, {"key": "licensed-territory", "type": "clause", "offset": [77, 95]}, {"key": "in-accordance-with", "type": "definition", "offset": [127, 145]}, {"key": "notice-to-licensee", "type": "clause", "offset": [289, 307]}, {"key": "consideration-election-notice", "type": "definition", "offset": [314, 343]}, {"key": "payment-of", "type": "definition", "offset": [347, 357]}], "hash": "fcaca63de53029f473c6f25829a1c3b7", "id": 5}, {"samples": [{"hash": "jX6wVHjWkL4", "uri": "/contracts/jX6wVHjWkL4#development-milestone", "label": "License and Collaboration Agreement (Cytokinetics Inc)", "score": 28.0527036277, "published": true}, {"hash": "eXRR7Up9KMr", "uri": "/contracts/eXRR7Up9KMr#development-milestone", "label": "License and Collaboration Agreement (Cytokinetics Inc)", "score": 27.8391512663, "published": true}], "size": 2, "snippet": "Subject to the remainder of this Section 9.3, Astellas shall pay to Cytokinetics non-refundable, non-creditable payments set forth in the table below, on an Indication-by-Indication basis, upon [*] achievement of each milestone event in such Indication(s) (whether by or on behalf of Astellas or its Affiliates or sublicensees) in accordance with Section 9.3(b):", "snippet_links": [{"key": "subject-to-the", "type": "definition", "offset": [0, 14]}, {"key": "section-93", "type": "clause", "offset": [33, 44]}, {"key": "pay-to", "type": "definition", "offset": [61, 67]}, {"key": "creditable-payments", "type": "clause", "offset": [101, 120]}, {"key": "milestone-event", "type": "clause", "offset": [218, 233]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [265, 283]}, {"key": "in-accordance-with", "type": "definition", "offset": [328, 346]}], "hash": "1f3a2038c94a94fd5837c40550562576", "id": 6}, {"samples": [{"hash": "2WTpB1iQA29", "uri": "/contracts/2WTpB1iQA29#development-milestone", "label": "License Agreement", "score": 29.340862423, "published": true}, {"hash": "9HSU3as6qbp", "uri": "/contracts/9HSU3as6qbp#development-milestone", "label": "License Agreement (Salix Pharmaceuticals LTD)", "score": 23.8528405202, "published": true}], "size": 2, "snippet": "(A) Salix shall pay to Alfa a one-time, non-refundable and non-creditable payment of twenty-five million Dollars ($25,000,000) (the \u201cDevelopment Milestone Payment\u201d) within [*] Business Days of receipt by Salix from Alfa of an invoice for the payment of the Development Milestone Payment following the issuance of the Initial U.S. Marketing Approval for the Crohn\u2019s EIR Product, provided that the Crohn\u2019s EIR Product has an Acceptable Product Profile. The Development Milestone Payment is payable one time only, regardless of the number of Crohn\u2019s EIR Products for which the condition is satisfied. For the avoidance of doubt, the maximum aggregate value of all Development Milestone Payments is twenty-five million Dollars ($25,000,000).\n(B) In the event that the specified condition for the Development Milestone Payment as specified above is achieved but in circumstances where the Crohn\u2019s EIR Product does not have an Acceptable Product Profile in connection with its Initial U.S. Marketing Approval, then the amount of the Development Milestone Payment shall be reduced to [*] (the \u201cDevelopment Milestone Reduction\u201d) and the Commercialization Milestone Payment of [*] payable upon [*] provided for in Section 4.1.2(b)(iii) shall be applicable. * Confidential treatment requested; certain information omitted and filed separately with the SEC.", "snippet_links": [{"key": "pay-to", "type": "definition", "offset": [16, 22]}, {"key": "business-days-of-receipt", "type": "clause", "offset": [176, 200]}, {"key": "by-salix", "type": "clause", "offset": [201, 209]}, {"key": "an-invoice", "type": "clause", "offset": [223, 233]}, {"key": "the-development", "type": "clause", "offset": [253, 268]}, {"key": "issuance-of-the", "type": "clause", "offset": [301, 316]}, {"key": "initial-us", "type": "clause", "offset": [317, 328]}, {"key": "marketing-approval", "type": "clause", "offset": [330, 348]}, {"key": "provided-that", "type": "clause", "offset": [378, 391]}, {"key": "product-profile", "type": "definition", "offset": [434, 449]}, {"key": "time-only", "type": "clause", "offset": [500, 509]}, {"key": "number-of", "type": "clause", "offset": [529, 538]}, {"key": "the-condition", "type": "clause", "offset": [570, 583]}, {"key": "for-the-avoidance-of-doubt", "type": "clause", "offset": [598, 624]}, {"key": "aggregate-value", "type": "definition", "offset": [638, 653]}, {"key": "development-milestone-payments", "type": "definition", "offset": [661, 691]}, {"key": "in-the-event", "type": "clause", "offset": [742, 754]}, {"key": "specified-condition", "type": "clause", "offset": [764, 783]}, {"key": "as-specified", "type": "clause", "offset": [822, 834]}, {"key": "in-connection-with", "type": "clause", "offset": [948, 966]}, {"key": "commercialization-milestone-payment", "type": "definition", "offset": [1129, 1164]}, {"key": "confidential-treatment-requested", "type": "definition", "offset": [1250, 1282]}, {"key": "certain-information", "type": "clause", "offset": [1284, 1303]}, {"key": "the-sec", "type": "definition", "offset": [1338, 1345]}], "hash": "879a1f09b467fc3d41ccdd3ad1e7a881", "id": 7}, {"samples": [{"hash": "hd4qY3u1r8G", "uri": "/contracts/hd4qY3u1r8G#development-milestone", "label": "Lease Agreement", "score": 22.1704312115, "published": true}, {"hash": "hiKq2OAIGFL", "uri": "/contracts/hiKq2OAIGFL#development-milestone", "label": "Lease Agreement", "score": 22.0458590007, "published": true}], "size": 2, "snippet": "The development milestone has been made in a way to ensure completion of development of Marriage Lawn within Three years of date of issue of NoA.\ni. The Developer shall secure all the required approvals permissions, NOC from the competent authority within six months from the date of issue of NoA\nii. The Developer shall complete minimum 50% of the construction of built-up area and development of Marriage Lawn in all respect within One and a half year from the date of issue of NoA\niii. The Developer shall complete construction work and development of Marriage lawn in all respect within Three years from the date of issue of NoA", "snippet_links": [{"key": "the-development", "type": "clause", "offset": [0, 15]}, {"key": "to-ensure", "type": "clause", "offset": [49, 58]}, {"key": "development-of", "type": "clause", "offset": [73, 87]}, {"key": "date-of-issue", "type": "definition", "offset": [124, 137]}, {"key": "developer-shall", "type": "clause", "offset": [153, 168]}, {"key": "required-approvals", "type": "clause", "offset": [184, 202]}, {"key": "competent-authority", "type": "definition", "offset": [229, 248]}, {"key": "six-months", "type": "definition", "offset": [256, 266]}, {"key": "construction-of", "type": "clause", "offset": [349, 364]}, {"key": "and-development", "type": "clause", "offset": [379, 394]}, {"key": "half-year", "type": "definition", "offset": [444, 453]}, {"key": "work-and", "type": "clause", "offset": [531, 539]}], "hash": "388f07ee784229df8167f4d50849a3f3", "id": 8}, {"samples": [{"hash": "kBozqesRWcK", "uri": "/contracts/kBozqesRWcK#development-milestone", "label": "Lease Cum Development Agreement", "score": 25.9397672827, "published": true}, {"hash": "52Ct6uTtOyx", "uri": "/contracts/52Ct6uTtOyx#development-milestone", "label": "Lease Cum Development Agreement", "score": 25.8357289528, "published": true}], "size": 2, "snippet": "(AS PER CLAUSE 5 OF RFP)", "snippet_links": [{"key": "clause-5", "type": "clause", "offset": [8, 16]}], "hash": "baf67c2632a11c8f6ae5f111e20972ef", "id": 9}, {"samples": [{"hash": "k3lrvH2DiTw", "uri": "/contracts/k3lrvH2DiTw#development-milestone", "label": "Collaboration Agreement (Momenta Pharmaceuticals Inc)", "score": 27.6666666667, "published": true}, {"hash": "8RjAAnABeHJ", "uri": "/contracts/8RjAAnABeHJ#development-milestone", "label": "Collaboration Agreement (Momenta Pharmaceuticals Inc)", "score": 27.3436002738, "published": true}], "size": 2, "snippet": "For M834, Mylan shall pay to Momenta [***] within [***] after the first achievement by or on behalf of Momenta of [***] (the \u201cDevelopment Milestone\u201d). Such Development Milestone payment shall be payable [***]. For clarity, if such Development Milestone event is not achieved, Mylan shall not owe the corresponding milestone payment.", "snippet_links": [{"key": "pay-to", "type": "definition", "offset": [22, 28]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [84, 102]}, {"key": "development-milestone-payment", "type": "definition", "offset": [156, 185]}, {"key": "for-clarity", "type": "clause", "offset": [210, 221]}, {"key": "development-milestone-event", "type": "definition", "offset": [231, 258]}], "hash": "4ce8178f8ec596ce544070401883116c", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih5kZXZlbG9wbWVudC1taWxlc3RvbmUjMDAwMDAwMGEMogECZW4YACAA", "clause": {"children": [["obligations-for-completion-of-mandatory-project-facilities-development-period-milestones", "Obligations for Completion of Mandatory Project Facilities - Development Period & Milestones"], ["other-project-facilities", "Other Project Facilities"], ["project-components", "Project Components"], ["mandatory-project-facilities", "Mandatory Project Facilities"], ["development-of-mandatory-and-other-project-facilities", "Development of Mandatory and other Project Facilities"]], "title": "Development Milestone", "size": 57, "parents": [["definitions", "Definitions"], ["definitions-interpretations", "Definitions Interpretations"], ["consideration", "Consideration"], ["financial-terms", "Financial Terms"], ["milestone-payments", "Milestone Payments"]], "id": "development-milestone", "related": [["development-milestones", "Development Milestones", "<strong>Development Milestones</strong>"], ["development-milestone-payments", "Development Milestone Payments", "<strong>Development Milestone</strong> Payments"], ["milestone-event-milestone-payment", "Milestone Event Milestone Payment", "Milestone Event Milestone Payment"], ["project-milestones", "Project/Milestones", "Project/Milestones"], ["milestone", "Milestone", "Milestone"]], "related_snippets": [], "updated": "2025-07-07T12:36:18+00:00", "also_ask": ["What objective criteria should define achievement of a development milestone?", "How can milestone deadlines be structured to balance flexibility and accountability?", "What are the most common disputes over milestone non-achievement, and how are they resolved in court?", "How do milestone provisions in this agreement compare to industry standards or similar deals?", "What remedies or consequences should be triggered by failure to meet a development milestone?"], "drafting_tip": "Specify milestone criteria, set deadlines, and outline consequences for delays to ensure clarity, accountability, and timely project completion.", "explanation": "A Development Milestone clause defines specific, measurable points of progress that must be achieved during a project\u2019s development phase. These milestones typically outline deliverables, deadlines, or performance criteria that the developer must meet, such as completing a prototype, passing certain tests, or delivering documentation. By establishing clear benchmarks, this clause helps track progress, ensures accountability, and provides a basis for evaluating whether the project is on schedule, thereby reducing ambiguity and managing expectations between parties."}, "json": true, "cursor": ""}}